ArticleJournal of the Chinese Medical Association : JCMA2025

Management of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer patients: First-line therapy.

Peng-Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.